Connect with us
[the_ad id="89560"]

COVID-19

COVID-19, Hygiene Theatre, Masks, and Lockdowns “Solid Science” or Science Veneer?

Published

23 minute read

From the Fraser Institute

By Kenneth P. Green

Nearly two and a half years since COVID-19 overturned much of the world, vigorous debate
still exists over whether or not governments “got COVID-19 right.” That is, despite more
than two years for analysis and retrospective studies, it is unclear if governments—any governments—implemented the best policies (or even 2nd best policies) as the COVID pandemic exploded in 2020, and as it unfolded through 2021 and 2022.

This situation is troubling, as the world will undoubtedly face similar, and perhaps more severe pandemic challenges again in the future. Society needs to know what worked and what did not work, not only with regard to vaccines, but with regard to the many other interventions government deployed to fight the COVID epidemic.

One key dispute regarding what went right or what went wrong with regard to COVID policies revolves around whether or not the public policies promulgated by governments and public health authorities were science- or evidence-based. Governments, regulatory bodies, and public health institutions around the world were not only unified, but strident in their proclamations that policies were “following the science.” Skeptics of such pronouncements were given little attention at the time, and were more often than not simply attacked as being peddlers of misinformation, or dis-information, and were squelched in public discourse. This did not, however, settle the dispute.

In fact, the battle lines over this question—whether governments were actually following the science or evidence available at the time, or were merely asserting that they were doing so—have only hardened since the pandemic struck in 2020. Even as this essay is being written, for example, a war is raging across Twitter (now “X”) between a prominent COVID vaccine researcher (Peter Hotez), and people who question whether his representation of his work is honest. The questioners seek a public debate, but the scientist involved (backed by many other prominent colleagues) have declared the very idea of societal debate to be anathema to the idea of science itself. The “Twitter war” over this dispute has drawn in one of the world’s richest men (Elon Musk), one of the world’s loudest populist broadcasters (Joe Rogan), and a host of high-level scientists and heads of scientific agencies (Mikhail, 2023).

This dynamic, of public accusations of obstruction, and demonizing of those making the accusations, bodes poorly for the prospects of improving future policy by learning from experience. It also bodes poorly for future confidence in governmental policy responses to threatening situations. It seems self-evident that the public will be less likely to follow governmental recommendations or guidance in future if the consensus develops that they cannot be trusted when they claim to be telling the truth, or following the evidence, or, as such truth-telling was cast in this case, “following the science.”

So what is the answer? Were governments following the science or the evidence extant at the time of COVID’s emergence and progression through the population, or were they following the science selectively, creating more of a veneer of science than a solid policy foundation of science?

Let’s examine this question by examining the two highly controversial, major non-pharmaceutical interventions, or NPIs, imposed during the COVID pandemic. NPIs implemented throughout the COVID-19 outbreak were policies intended to slow or limit the spread of the virus, and to reduce risk of infection via measures of physical separation including: enhanced hygiene, social distancing (keeping separate from others at a distance of 2 meters), erecting physical air/particle barricades, wearing gloves, donning masks, accepting voluntary and involuntary isolation, and a variety of restrictions on assemblage, including closures of parks, businesses, schools, and houses of worship, etc.

Gathering restrictions/closures (bars, businesses, churches, schools)

Several articles have looked into the question of “what the science said” about gathering restrictions imposed in response to COVID-19: closures of businesses, schools, public gatherings, etc., as that science already existed in 2020, and before.

The Cochrane Library, a respected clearinghouse of scientific and medical information,
published one such retrospective look at “the science” conducted in mid-2020, and entitled Quarantine Alone or in Combination with Other Public Health Measures to Control COVID-19: A Rapid Review (Nussbaumer-Streit, 2020; for simplicity, Nussbaumer).

Nussbaumer searched for studies related to quarantine efficacy on the PubMed, Ovid MEDLINE, WHO Global Index Medicus, Embase, and CINAHL databases on June 23, 2020, only about six months into the pandemic. Nussbaumer specifically searched for “Cohort studies, case-control studies, time series, interrupted time series, case series, and mathematical modelling studies that assessed the effect of any type of quarantine to control COVID-19.” The authors even included studies on SARS (Severe Acute Respiratory Syndrome) and MERS (Middle East Respiratory Syndrome) for indirect evidence that might apply to COVID-19. The net was cast widely. Nussbaumer identified 51 studies that met their criteria for inclusion in their analysis. Ten were modeling studies on COVID19; 15 were modelling studies of SARS and MERS; and the team found four observational studies
on SARS and MERS.

Nussbaumer found that while modeling studies were uniform in predicting that quarantine, in a variety of forms, would effectively reduce transmission of SARS, MERS, or COVID-19, the quality of evidence from these modeling studies was characterized as having low certainty or very low certainty, and the studies were, primarily, as the authors themselves noted, “modeling studies that make parameter assumptions based on the current, fragmented knowledge.”1

1 The four observational studies identified suggested quarantine was effective as a control strategy for SARS and MERS. However, Nussbaumer deemed them unlikely to be reflective of COVID-19 controls.

School closures

As discussed in a separate essay on the issue of school closures and educational performance (McPherson and Green, 2023), the question of whether school closures reduced either children’s risk directly, or society’s risk of COVID-contagion vie exposure to children, remains an important and particularly contentious area of debate. We are still trying to assess the damage done to children’s educational attainment in the nearly three years of intermittent school closures in Canada, and it will be some time before the extent of that damage is well understood. Longer term impacts on children’s mental health and social development will likely take many years to ascertain.

When COVID-19 struck in 2020, understanding how school closures related to the spread of a virus through school populations were based mostly on studies of Influenza pandemics that preceded COVID.

In another Cochrane Library review of studies on school closures published as of December 2020, the team of Krishnaratne et al. surveyed research on the issue of school closures published in “the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE, Embase, and the Educational Resources Information Center, as well as COVID-19-specific databases, including the Cochrane COVID-19 Study Register and the WHO COVID-19 Global literature on coronavirus disease” (2022). They found 38 unique studies in their analysis, 33 of which were modeling studies, three of which were observational studies, one study that was described as “quasi-experimental,” and one “experimental study with modelling components.”

Krishnaratne et al. concluded that

  • a broad range of measures implemented in the school setting can have positive impacts
    on the transmission of SARS-CoV-2, and on healthcare utilisation outcomes related
    to COVID-19. The certainty of the evidence for most intervention-outcome combinations is very low, and the true effects of these measures are likely to be substantially
    different from those reported here. Measures implemented in the school setting may
    limit the number or proportion of cases and deaths, and may delay the progression
    of the pandemic. However, they may also lead to negative unintended consequences,
    such as fewer days spent in school (beyond those intended by the intervention).
    (Krishnaratne et al., 2022)

This aligns with by another review of the literature published in the British Medical Journal in 2023. In that paper, Hume et al. characterized the findings of 26 systemic reviews pertinent to the school-transmission question. They conclude, “We found evidence that both school closures and in-school mitigations may have had a beneficial impact on reducing COVID-19 transmission in the community. However, the GRADE [a measure of research quality] certainty was very low in both outcomes. We also found that school closures may have had negative impacts on children, including reduced learning, increased anxiety and increased rates of obesity. However, GRADE certainties were low or very low in these outcomes. Overall, confidence in the included SRs was generally low or critically low” (Hume, et al., 2023).

Other studies pre-dating COVID-19 also raised questions about the potential utility of school closures. One of the more interesting studies on the question from much farther back—a decade back, in fact—came out of University College London, by a research
team that included Neil M. Ferguson, the same researcher whose initial modeling of COVID-19 shaped the world’s response to the pandemic. That study concluded regarding school closures for Influenza, “Although some health benefits can be expected, there is
still substantial debate about if, when, and how school closure policy should be used. There is no consensus on the scale of the benefits to be expected, and recent reviews highlighted the lack of evidence for social distancing measures such as school closure. Even if benefits are substantial, they must be weighed against the potential high economic and social costs of proactively closing schools, which also can have negative effects on key workers since, for example, many doctors and nurses are also parents” (Cauchemez et al, 2009).

  • “School closures may have had negative impacts on children, including reduced learning, increased anxiety and increased rates of obesity.”

Enhanced Hygiene: Hand-washing, mask-wearing, and social distancing

The Cochrane Library has again been a world leader in performing retrospective reviews of the effectiveness (and state of knowledge) regarding interventions intended to manage the COVID-19 pandemic.

In 2020, the research team of Jefferson et al. searched the extant scientific literature and
published its findings in the Cochrane Library’s Physical Interventions to Interrupt or Reduce the Spread of Respiratory Viruses. Searching an array of medical and scientific literature indices and databases, the Jefferson team amassed a total of 67 studies which met the criteria for inclusion in their retrospective analysis of the evidence regarding enhanced hygiene (hand-washing and mask-wearing). All of these studies pre-dated the COVID-19 pandemic and focused on previous disease outbreaks of influenza, including the highly virulent H1:N1 variant that wrought worldwide havoc in 2009.

As there is unusually contentious debate over Cochrane’s research on this topic (a fairly vicious battle between the “masks don’t work” and “masks do work” tribes), it is best to read the team’s conclusions in the authors’ own words:

  • The high risk of bias in the trials, variation in outcome measurement, and relatively low compliance with the interventions during the studies hamper drawing firm conclusions and generalising the findings to the current COVID-19 pandemic. There is uncertainty about the effects of face masks. The low-moderate certainty of the evidence means our confidence in the effect estimate is limited, and that the true effect may be different from the observed estimate of the effect. The pooled results of randomized trials did not show a clear reduction in respiratory viral infection with the use of medical/surgical masks during seasonal influenza. There were no clear differences between the use of medical/surgical masks compared with N95/P2 respirators in healthcare workers when used in routine care to reduce respiratory viral infection. Hand hygiene is likely to modestly reduce the burden of respiratory illness. Harms associated with physical interventions were under-investigated. (Jefferson et al., 2020: 2–3).

Team Jefferson would update this research in 2023, amassing an expanded set of 78 randomized clinical trials involving physical interventions that had been conducted prior to the time of search (Jefferson et al., 2023). Most of those studies were also conducted prior to the COVID-19 outbreak, and studied the effectiveness of physical interventions against various types of influenza. However, six of the studies included in the 2023 review were conducted during the COVID-19 pandemic.

I’ll also reproduce this latest summary of findings from Jefferson et al. in the authors’ own
words:

  • There is uncertainty about the effects of face masks. The low to moderate certainty
    of evidence means our confidence in the effect estimate is limited, and that the true
    effect may be different from the observed estimate of the effect. The pooled results
    of RCTs did not show a clear reduction in respiratory viral infection with the use of
    medical/surgical masks. There were no clear differences between the use of medical/
    surgical masks compared with N95/P2 respirators in healthcare workers when used in
    routine care to reduce respiratory viral infection. Hand hygiene is likely to modestly
    reduce the burden of respiratory illness, and although this effect was also present
    when ILI [Influenza-Like Illness] and laboratory-confirmed influenza were analysed
    separately, it was not found to be a significant difference for the latter two outcomes.
    Harms associated with physical interventions were under-investigated. (Jefferson et
    al., 2023: 3).

Discussion

Governments and government policies were deeply involved in the development, definition, and deployment of both pharmaceutical and non-pharmaceutical interventions throughout the COVID pandemic, far more directly than was routinely seen in past public health crises or in contagious disease outbreaks. Whereas in the past one might have consulted with one’s doctor to get an idea about what to do to protect one’s health, there was no need for that in 2020: government pronouncements at the highest levels of health care bureaucracy were loud, clear, and insistent from the earliest days of the COVID pandemic.

At the time, governments, regulatory agencies, and a vast panoply of public health authorities asserted that they were, in all cases, diligently “following the science” in the policy guidances and prescriptions they wrote for society. “Following the science” became a constant refrain in explaining everything government did. It was also a bludgeon when used in the negative: “not following the science” was applied to anyone critical of what government did. And despite the fact that science is generally a relatively slow process of theory, experimentation, and publication of findings, somehow, as of January 2020, “the science” took to changing on a daily, even hourly basis.

Despite government assertions that they were following the science, reviews of the literature on the subject extant at the time suggest that governments were selectively interpreting the studies that already existed.

In fact, studies regarding the effectiveness of the measures governments adopted to fight COVID were relatively few in number, were mostly in the past tense as of 2020, were largely characterized as having mixed results, were highly uncertain, and were primarily driven by computer models.

The “consensus” of reviews of the literature extant at the time, conducted both during 2020 and afterward, come to basically the same conclusions. Specifically, they find with regard to the non-pharmaceutical interventions of enhanced hygiene, mask-wearing, and restrictions on gathering that while these NPIs might have helped, they might also have harmed, but that there was no strong evidence one way or the other.

Thus, it’s safe to say that while governments did not actively lie about “following the science,” they most certainly misrepresented “the science” in that they exaggerated certainty (a constant problem of government), they chose to believe models over observational studies, they only acknowledged half the science (about slowing transmission, not about causing harm to people economically and socially), and they spoke in tones of absolute certainty that denied the essence of science. That essence understands that knowledge is provisional, that this was a novel virus, and that there was, in fact, no
solid reason to find prior research outcomes dispositive in terms of giving guidance about what to do.

In acting with such certainty, governments not only did harm to their own future credibility, but they did harm to the credibility of public health institutions, biomedical institutions, pharmaceutical institutions, and others that governments chose to use as fig-leaves to obscure what were, in very large measure, arbitrary choices that governments made based on fragmentary, cherry-picked, model-dominated studies that mostly pre-existed the COVID pandemic. At the same time, governments also suppressed dissent among and elevated the authoritarian voices and managers of those institutions.

In an ideal world, there would be some process by which our public health agencies, at least, could come to recognize and admit how badly they managed to “follow the science” on COVID-19, and how vast was the gulf between their expressions of absolute certainty and what the scientific literature showed at the time was, in fact, a sea of uncertainty. Until such a “truth and reconciliation” process takes place, it is hard to see how public trust in public health institutions might be restored.

About the author

Kenneth P. Green is a Fraser Institute senior fellow and author of over 800 essays and articles on public policy, published by think tanks, major newspapers, and technical and trade journals in North America. Mr. Green holds a doctoral degree in environmental science and engineering from UCLA, a master’s degree in molecular genetics from San Diego State University, and a bachelors degree in general biology from UCLA.

Todayville is a digital media and technology company. We profile unique stories and events in our community. Register and promote your community event for free.

Follow Author

COVID-19

Florida COVID grand jury finds ‘profound and serious issues’ in vaccine regulation, oversight

Published on

From LifeSiteNews

By Calvin Freiburger

The grand jury commissioned by Gov. DeSantis has released its long-awaited final report on the manufacture and rollout of the COVID shots, finding no actionable crimes under current law but still identifying ‘profound and serious issues involving the process of vaccine development and safety surveillance in the United States.’

A Florida grand jury has released its final report on the manufacture and rollout of the COVID-19 shots, finding no actionable crimes under current law but still identifying “profound and serious issues involving the process of vaccine development and safety surveillance in the United States” for policymakers to resolve.

In December 2022, Republican Gov. Ron DeSantis petitioned the Florida Supreme Court to approve a grand jury to determine whether pharmaceutical companies and other medical organizations “engaged in criminal activity or wrongdoing” pertaining to the controversial and harmful shots.

In February 2024, it released its first interim report, which decided that before assessing the shots it first had to understand the risk posed by COVID itself, and so concluded that the 2020 lockdowns did more harm than good, masks were ineffective at stopping the virus, COVID was “statistically almost harmless” to children and most adults, and it was “highly likely” that COVID hospitalization numbers were inflated.

On Tuesday, the grand jury released its final 144-page report. It opens with the somewhat surprising declaration that two conflicting statements – “COVID-19 vaccines were a triumph of science, technology and public health that saved countless lives”; and “COVID-19 vaccines were heedlessly licensed, excessively recommended, and even mandated to broad swathes of people that did not need them, placing their health-and sometimes their lives-at unnecessary risk” – are “both true.”

READ: Peer-reviewed study finds over 1,000% rise in cardiac deaths after COVID-19 shots

The grand jury maintains that the first Trump administration’s Operation Warp Speed initiative “produced an effective vaccine in early 2021 that dramatically reduced many of the risks associated with SARS-CoV-2,” but “all the goodwill generated by that amazing achievement was squandered in the following years, as sponsors and federal regulators collaborated to push out booster after booster based on shallow, inaccurate safety and efficacy data, sidelining their own ombudsmen to get doses of these vaccines into the arms of every American, regardless of their underlying risk from the SARS-CoV-2 virus.”

“Our investigative efforts in both of those categories were directed in large part towards Pfizer and Modema, whose rnRNA-based vaccines were the primary focus of our investigation,” the report adds. “Suffice it to say that while we are certain we have not seen everything these companies created with respect to these products (Pfizer essentially admitted this fact), we did receive a lot of relevant information from them, more than we could ever hope to meaningfully review in our limited term. Many of our conclusions are informed by documents we received or on testimony given by their representatives.”

The report condemns Big Pharma’s reluctance to shed light on the full extent of the problem, and the lack of recourse when the worst does happen.

“It is frustrating to this Grand Jury, as it should be frustrating to everyone who reads this report, to know that these sponsors have taken in billions of taxpayer dollars for creating and selling their vaccines; they cannot be sued if something goes wrong with them; they have access to critical information about deaths related to a side effect of their products; and the public does not have access to that information,” it says. “Instead, we are left to speculate, and the research community is left to draw inferences as one-off or two-off histopathological reports detailing the events of this death or that death that trickle into scientific journals slowly, year after year. Somehow, withholding this valuable safety information is not a crime. It certainly should be.”

While its conclusions will be thoroughly dissected by many experts and activists in the days to come, the report’s most immediate takeaway is that current law is inadequate to cure the problems investigators uncovered.

“While we did not find criminal activity, we did find a pattern of deceptive and obfuscatory behavior on the part of sponsors and regulators that often straddled the line between ethical and unethical conduct,” the report says. “More importantly, however, not finding any indictable criminal activity does not mean we did not find any problems. On the contrary, there are profound and serious issues involving the process of vaccine development and safety surveillance in the United States. Some of those are acute, COVID-19-era problems that are unlikely to occur outside the context of another once-in-a-hundred-year pandemic. Others, however, are systemic; they will occur over and over until someone fixes them.”

The report says “it was genuinely striking to us just how many of the problems we found occurred at either the direction or acquiescence of the FDA [U.S. Food & Drug Administration], CDC [Centers for Disease Control & Prevention] and other federal regulators. Nearly every time we found an issue with MRNA-1273 [the Moderna shot] or BNT162b2 [the Pfizer shot], the fingerprints of these agencies were all over the scene, advising that the flagship and surrogate clinical trials be performed in specific ways, authorizing dose after dose and formulation after formulation based on out-of-date immunogenicity comparisons and observational results, and even running interference for sponsors by misleading the American public about validated safety signals.”

To the federal government, the grand jury recommends new clinical trials of both mRNA-based COVID shots, reinstatement of the FDA’s old ban on direct-to-consumer advertising of therapeutics, new controls on the hiring of medical industry insiders and lobbyists for health regulatory positions, restructuring the Vaccines & Related Biological Products Advisory Committee (VRBPAC) for greater accountability, mandatory disclosure of anonymized individual patient data as a condition of FDA licensure, and making safety data transparency a condition of liability protection. To the state of Florida, it recommends a series of changes to strengthen grand juries’ ability to obtain the information they seek, as well as more widespread monitoring of wastewater for pathogens.

DeSantis said Tuesday that while his office was still reviewing the report’s details, it was clear that “Big Pharma brought in billions of dollars in profit, and the federal government amplified bogus ‘studies,’ all while suppressing any opposition that went against their preferred narrative. Instead of federal agencies acting as a backstop to bad incentives, they worked closely with Big Pharma as they cut corners, even becoming unpaid advertisers on their behalf.”

“The Grand Jury has made a number of recommendations that should be followed,” the governor declared. “The status quo cannot continue. The American people deserve transparency on how Big Pharma is using their federal tax dollars, and they deserve regulating entities that operate as watchdogs, not cheerleaders.”

 

The report follows a large body of evidence that identifies significant risks to the COVID shots, which were developed and reviewed in a fraction of the time vaccines usually take under the first Trump administration’s Operation Warp Speed initiative.

The federal Vaccine Adverse Event Reporting System (VAERS) reports 38,190 deaths, 219,170 hospitalizations, 22,082 heart attacks, and 28,769 myocarditis and pericarditis cases as of November 29, among other ailments. CDC researchers have recognized a “high verification rate of reports of myocarditis to VAERS after mRNA-based COVID-19 vaccination,” leading to the conclusion that “under-reporting is more likely” than over-reporting.

An analysis of 99 million people across eight countries published February in the journal Vaccine “observed significantly higher risks of myocarditis following the first, second and third doses” of mRNA-based COVID injections, as well as signs of increased risk of “pericarditis, Guillain-Barré syndrome, and cerebral venous sinus thrombosis,” and other “potential safety signals that require further investigation.” In April, the CDC was forced to release by court order 780,000 previously undisclosed reports of serious adverse reactions, and a study out of Japan found “statistically significant increases” in cancer deaths after third doses of mRNA-based COVID-19 shots and offered several theories for a causal link.

All eyes are currently on returning President Donald Trump and his health team, which will be helmed by prominent vaccine critic Robert F. Kennedy Jr. as his nominee for Secretary of Health & Human Services. Trump has given mixed signals as to the prospects of reconsidering the shots for which he has long taken credit and has nominated both critics and defenders of establishment COVID measures for a number of administration roles.

Continue Reading

COVID-19

Report Shows Politics Trumped Science on U.S. Vaccine Mandates

Published on

From the Frontier Centre for Public Policy

By Lee Harding

If you thought responsible science drove the bus on the pandemic response, think again. A December 2024 report by the U.S. House of Representatives Select Subcommittee, Coronavirus Pandemic shows that political agendas made regulatory bodies rush vaccine approvals, mandates, and boosters, causing public distrust.

After Action Review of the COVID-19 Pandemic: The Lessons Learned and a Path Forward” praised the Trump administration’s efforts to speed up vaccine development. By contrast, the report said presidential candidate Joe Biden and vice-presidential candidate Kamala Harris undermined public confidence.

“[W]hy do we think the public is gonna line up to be willing to take the injection?” Joe Biden asked on September 5, 2020. This quote appeared in a Politico article titled “Harris says she wouldn’t trust Trump on any vaccine released before [the] election.”

The House report noted, “These irresponsible statements eventually proved to be outright hypocrisy less than a year later when the Biden-Harris Administration began to boldly decry all individuals who decided to forgo COVID-19 vaccinations for personal, religious, or medical reasons.”

Millions of doses of COVID-19 vaccines were administered beginning in December 2020 under an Emergency Use Authorization. This mechanism allows unapproved medical products to be used in emergency situations under certain criteria, including that there are no alternatives. The only previous EUA was for the 2004 anthrax vaccine, which was only administered to a narrow group of people.

By the time vaccines rolled out, SARS-CoV-2 had already infected 91 million Americans. The original SARS virus some 15 years prior showed that people who recovered had lasting immunity. Later, a January 2021 study of 200 participants by the La Jolla Institute of Immunology found 95 per cent of people who had contracted SARS-CoV-2 (the virus behind COVID-19) had lasting immune responses. A February 16, 2023 article by Caroline Stein in The Lancet (updated March 11, 2023) showed that contracting COVID-19 provided an immune response that was as good or better than two COVID-19 shots.

Correspondence suggests that part of the motivation for full (and not just emergency) vaccine approval was to facilitate vaccine mandates. A July 21, 2021, email from Dr. Marion Gruber, then director of vaccine reviews for the Food and Drug Administration (FDA), recalled that Dr. Janet Woodcock had stated that “absent a license, states cannot require mandatory vaccination.” Woodcock was the FDA’s Principal Deputy Commissioner at the time.

Sure enough, the FDA granted full vaccine approval on August 23, 2021, more than four months sooner than a normal priority process would take. Yet, five days prior, Biden made an announcement that put pressure on regulators.

On August 18, 2021, Biden announced that all Americans would have booster shots available starting the week of September 20, pending final evaluation from the FDA and the U.S. Centers for Disease Control and Prevention (CDC).

Some decision-makers objected. Dr. Marion Gruber and fellow FDA deputy director of vaccine research Dr. Philip Krause had concerns regarding the hasty timelines for approving Pfizer’s primary shots and boosters. On August 31, 2021, they announced their retirements.

According to a contemporary New York Times article, Krause and Gruber were upset about Biden’s booster announcement. The article said that “neither believed there was enough data to justify offering booster shots yet,” and that they “viewed the announcement, amplified by President Biden, as pressure on the F.D.A. to quickly authorize them.”

In The Lancet on September 13, 2021, Gruber, Krause, and 16 other scientists warned that mass boosting risked triggering myocarditis (heart inflammation) for little benefit.

“[W]idespread boosting should be undertaken only if there is clear evidence that it is appropriate,” the authors wrote. “Current evidence does not, therefore, appear to show a need for boosting in the general population, in which efficacy against severe disease remains high.”

Regardless, approval for the boosters arrived on schedule on September 24, 2021. CDC Director Dr. Rochelle Walensky granted this approval, but for a wider population than recommended by her advisory panel. This was only the second time in CDC history that a director had defied panel advice.

“[T]his process may have been tainted with political pressure,” the House report found.

Amidst all this, the vaccines were fully licensed. The FDA licensed the Comirnaty (Pfizer-BioNTech) vaccine on August 23, 2021. The very next day, Defense Secretary Lloyd Austin issued a memo announcing a vaccine mandate for the military. Four other federal mandates followed.

“[T]he public’s perception [is] that these vaccines were approved in a hurry to satisfy a political agenda,” the House report found.

The House report condemned the dubious process and basis for these mandates. It said the mandates “ignored natural immunity, … risk of adverse events from the vaccine, as well as the fact that the vaccines don’t prevent the spread of COVID-19.”

The mandates robbed people of their livelihoods, “hollowed out our healthcare and education workforces, reduced our military readiness and recruitment, caused vaccine hesitancy, reduced trust in public health, trampled individual freedoms, deepened political divisions, and interfered in the patient-physician relationship,” the report continued.

The same could be said of Canadian vaccine mandates, as shown by the National Citizen’s Inquiry hearings on COVID-19. Unfortunately, an official federal investigation and a resulting acknowledgement do not seem forthcoming. Politicized mandates led to profits for vaccine manufacturers but left “science” with a sullied reputation.

Lee Harding is a Research Fellow for the Frontier Centre for Public Policy.

Continue Reading

Trending

X